The numbers: Fiscal first-quarter net income increased 18% to $4.4 million, or 29 cents a share, as revenue grew 12% to $32 million. Neogen's gross margin rose from 55% to 57%, and its operating margin expanded from 20% to 21%. The company has an ideal financial position, with $24 million of cash and no debt.
The stock: Neogen has climbed 34% this year, outpacing the Dow and S&P 500. The stock trades at a price-to-earnings ratio of 35, a premium to the market and health care supply peers. The company doesn't pay dividends.